StockWatch
·

ISHITA DRUGS & INDUSTRIES LTD. Q4 FY25 Results

ISHITADRQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue4.5610.4%
Total Income4.7212.5%
Expenditure4.3411.8%
PBT0.3820.3%
Net Profit0.2921.0%
OPM6.39%1.43pp
NPM6.10%0.43pp
EPS0.9620.0%
View full financials

Informational and educational content only. Not investment advice.